Hi, what are you looking for?
Jewish Business News
Search results for "TEVA"
Business
New Teva CEO Kare Schultz will earn an annual salary of $2 million and a performance-dependent bonus of 140% - and up to a...
Life science
Kare Schultz brings Global Pharmaceutical experience, Including at Lundbeck and Novo Nordisk Proven Track Record of Implementing Turnaround Strategies
Business
Teva Pharmaceutical Industries Ltd. today announced the launch of generic Axiron (testosterone) topical solution CIII, 30 mg/1.5 mL, in the US. Testosterone topical solution...
Business
The Israeli Pharma share is losing about 33% in two trading days and erasing a huge sum of $10 billion from its market value
Business
Teva will close 15 plants by the end of 2018 and exit from 45 countries by the end of 2017 ■ The company expects...
Business
Judge rules against Israeli pharma firm in its suit over alleged fraud by Mexican Espinosa brothers; Teva posts $5.7 billion 2Q revenue - less...
Court
Teva demands compensation from the employee for the malicious transfer of trade secrets and confidential information, and punitive damages.
Business
The CONCERTO trial of laquinimod in patients with relapsing-remitting multiple sclerosis did not meet its primary endpoint.
Life science
Teva bribery: An investigation is being conducted in Israel regarding the same issues which led to a settlement with American justice authorities.
Business
Teva appointed Dr. Yitzhak Peterburg as Interim, succeeding Erez Vigodman. Dr. Sol J. Barer named Chairman of the Board